Evidence map›Paper›PMID 42297143›Full record

ReviewAdvances in nutrition (Bethesda, Md.)2026

Dairy Processing and Breast Cancer: A Hypothesis-Generating Framework Linking Bioactive Lipid Derivatives to Epidemiological Heterogeneity.

Silia Ayadi, Julio Buñay, Chloé Gressein, Laly Pucheu, Ben Allal, Philippe de Médina, Sandrine Silvente-Poirot, Marc Poirot

Abstract readReview
In one paragraph

Review in Advances in nutrition (Bethesda, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Silia AyadiTeam INOV: "Cholesterol metabolism and therapeutic innovations", Centre de Recherche en Cancérologie de Toulouse, INSERM, CNRS, University of Toulouse, Toulouse, France.
Julio BuñayTeam INOV: "Cholesterol metabolism and therapeutic innovations", Centre de Recherche en Cancérologie de Toulouse, INSERM, CNRS, University of Toulouse, Toulouse, France.
Chloé GresseinTeam INOV: "Cholesterol metabolism and therapeutic innovations", Centre de Recherche en Cancérologie de Toulouse, INSERM, CNRS, University of Toulouse, Toulouse, France.
Laly PucheuTeam INOV: "Cholesterol metabolism and therapeutic innovations", Centre de Recherche en Cancérologie de Toulouse, INSERM, CNRS, University of Toulouse, Toulouse, France.
Ben AllalTeam DIAD: "Dose individualization of anticancer drugs," Centre de Recherche en Cancérologie de Toulouse, INSERM, CNRS, University of Toulouse, Toulouse, France; Institut Claudius Regaud, Institut Universitaire du Cancer-Oncopole, Toulouse, France.
Philippe de MédinaTeam INOV: "Cholesterol metabolism and therapeutic innovations", Centre de Recherche en Cancérologie de Toulouse, INSERM, CNRS, University of Toulouse, Toulouse, France. Electronic address: philippe.de-medina@inserm.fr.
Sandrine Silvente-PoirotTeam INOV: "Cholesterol metabolism and therapeutic innovations", Centre de Recherche en Cancérologie de Toulouse, INSERM, CNRS, University of Toulouse, Toulouse, France. Electronic address: sandrine.poirot@inserm.fr.
Marc PoirotTeam INOV: "Cholesterol metabolism and therapeutic innovations", Centre de Recherche en Cancérologie de Toulouse, INSERM, CNRS, University of Toulouse, Toulouse, France. Electronic address: marc.poirot@inserm.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The relationship between dairy consumption and breast cancer risk remains complex and heterogeneous, with epidemiological studies reporting divergent associations depending on the type of dairy product and its degree of processing. Although nutritional composition has traditionally been considered the main explanatory factor, emerging evidence suggests that technological processing may also influence the biological properties of dairy foods. In this narrative review, we propose a hypothesis-generating framework that integrates epidemiological findings with experimental data on lipid oxidation and sterol-derived metabolites produced during dairy processing. In particular, cholesterol oxidation products and other bioactive lipid derivatives have been shown in experimental models to modulate pathways involved in inflammation, oxidative stress, and hormone signaling. However, direct evidence linking dietary exposure to these compounds and breast cancer risk in humans remains limited. Recent research highlights that food processing may generate a wide range of bioactive molecules beyond conventional nutrients, some of which may act at low concentrations and influence key regulatory pathways. These include both potentially deleterious and protective sterol-derived metabolites, whose balance may be affected by technological processing. Identifying such compounds, quantifying their dietary exposure, and understanding their biological effects represent important challenges for future research. Although current evidence remains insufficient to establish causal relationships, this framework supports the hypothesis that processing-related molecular changes may contribute to the heterogeneity observed in epidemiological studies.

Indexed as

Breast NeoplasmsDairy ProductsDietFood HandlingFemaleHumansLipid MetabolismOxidation-ReductionOxidative StressRisk FactorsSterolsSterolsbioactive lipidsbreast cancerdairy productsfood processingIGF-1lipid oxidationnutritional epidemiologyoxysterolssterol metabolismultraprocessed foods

Identifiers

PMID42297143
PMCPMC13352057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.